Efficacy of ustekinumab in palmoplantar psoriasis.
Bulai Livideanu
C
C
Lahfa
M
M
Mazereeuw-Hautier
J
J
Paul
C
C
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D003879:Dermatologic Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D009765:Obesity / Q000188:drug therapy; D011565:Psoriasis / Q000188:drug therapy*; D012907:Smoking; D016896:Treatment Outcome; D000079424:Tumor Necrosis Factor Inhibitors; D000069549:Ustekinumab; D014807:Vitamin D / Q000031:analogs & derivatives
D000305:Adrenal Cortex Hormones; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D003879:Dermatologic Agents; D000079424:Tumor Necrosis Factor Inhibitors; D014807:Vitamin D; D000069549:Ustekinumab; D008727:Methotrexate